Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Volitionrx Ltd as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −7 vs. Q2 2021
- Shares held
- 6.18M
- −277.6K (−4.3%) vs. Q2 2021
- Total value
- $19.2M
- −$2.09M (−9.8%) vs. Q2 2021
- New holders
- 2
- 7 more added
- Sold out
- 9
- 16 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 100 | $0 | 0.00% | −3,918−97.5% | Reduced |
| Royal Bank of Canada | 31 | $0 | 0.00% | −1,373−97.8% | Reduced |
| Group One Trading, L.P. | 150 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 225 | $1.00K | 0.00% | −6−2.6% | Reduced |
| BNP Paribas Arbitrage, SA | 393 | $1.22K | 0.00% | +82+26.4% | Added |
| Simplex Trading, LLC | 802 | $2.00K | 0.00% | 00.0% | Unchanged |
| Total Clarity Wealth Management, Inc. | 720 | $2.00K | 0.00% | +720 | New |
| UBS Group AG | 1,876 | $6.00K | 0.00% | −1,717−47.8% | Reduced |
| Bank of America Corp | 2,598 | $8.00K | 0.00% | −12,860−83.2% | Reduced |
| Founders Capital Management | 3,000 | $9.00K | 0.01% | 00.0% | Unchanged |
| Barclays PLC | 3,160 | $10.0K | 0.00% | −5,329−62.8% | Reduced |
| Credit Agricole S A | 4,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| Hartford Financial Management Inc. | 5,000 | $16.0K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 8,885 | $27.5K | 0.00% | 00.0% | Unchanged |
| MTM Investment Management, LLC | 10,000 | $31.0K | 0.02% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 15,384 | $48.0K | 0.00% | 00.0% | Unchanged |
| Garrison Bradford & Associates Inc | 15,500 | $48.0K | 0.05% | 00.0% | Unchanged |
| Creative Planning | 16,160 | $50.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 16,320 | $51.0K | 0.00% | −1,100−6.3% | Reduced |
| Citadel Advisors LLC | 19,075 | $59.0K | 0.00% | +19,075 | New |
| Bank of New York Mellon Corp | 21,828 | $68.0K | 0.00% | −530−2.4% | Reduced |
| Dimensional Fund Advisors LP | 22,385 | $69.0K | 0.00% | −4,275−16.0% | Reduced |
| Rinet Co LLC | 25,000 | $78.0K | 0.01% | 00.0% | Unchanged |
| Credit Suisse AG | 29,539 | $92.0K | 0.00% | −2,256−7.1% | Reduced |
| Spectrum Asset Management, Inc. (NB/CA) | 55,596 | $172.0K | 0.05% | 00.0% | Unchanged |
| Cowen Prime Advisors LLC | 62,200 | $193.0K | 0.07% | +3,000+5.1% | Added |
| Millennium Management LLC | 63,337 | $196.0K | 0.00% | −211,889−77.0% | Reduced |
| Northern Trust Corp | 63,219 | $196.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 65,570 | $203.0K | 0.00% | +2,997+4.8% | Added |
| Susquehanna International Group, LLP | 70,575 | $219.0K | 0.00% | +15,541+28.2% | Added |
| State Street Corp | 104,823 | $325.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 128,700 | $399.0K | 0.00% | −117,917−47.8% | Reduced |
| Ergoteles LLC | 134,100 | $416.0K | 0.02% | −900−0.7% | Reduced |
| Bridgeway Capital Management, LLC | 266,100 | $825.0K | 0.02% | −37,200−12.3% | Reduced |
| Geode Capital Management, LLC | 270,820 | $839.0K | 0.00% | +8,718+3.3% | Added |
| Vanguard Group Inc | 511,758 | $1.59M | 0.00% | +12,673+2.5% | Added |
| BlackRock Inc. | 537,351 | $1.67M | 0.00% | −14,329−2.6% | Reduced |
| Morgan Stanley | 582,509 | $1.80M | 0.00% | −26,664−4.4% | Reduced |
| Lagoda Investment Management, L.P. | 3,043,344 | $9.43M | 4.70% | +315,341+11.6% | Added |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −35,798−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −26,387−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −25,700−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −15,126−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −13,735−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −11,503−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −247−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Cowen Prime Services LLC | – | – | – | – | Not filed |